Mild cases of uveitis can often be managed with eye drops or ointments containing corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs). The benefit of topical medications is that they provide targeted treatment to the affected eye while minimizing systemic side effects. However, prolonged use of corticosteroid eye drops can increase the risk of cataracts and glaucoma. Regular monitoring and close follow-up with an ophthalmologist are necessary to balance the benefits of symptom relief with the potential risks of long-term use.
In moderate to severe cases of uveitis or when topical Uveitis Treatment is insufficient, systemic medications may be prescribed. These can include corticosteroids, immunosuppressants, biologic agents, or other disease-modifying anti-rheumatic drugs (DMARDs). The benefits of systemic medications lie in their ability to control inflammation throughout the body and reduce the risk of complications. However, these medications can have significant side effects, such as increased susceptibility to infections, bone loss, and systemic immunosuppression. Close monitoring and regular check-ups are necessary to mitigate these risks and optimize treatment outcomes.
Explore More- https://cmiblogdailydose.blogspot.com/2023/06/uveitis-treatment-includes-topical.html
Comments
0 comment